N-[(2S,4R,5S)-5-[(2S,5S)-3-acetamido-5-[(2S,4S,5R)-3-acetamido-5-[(2S,5S)-3-acetamido-6-ethyl-5-[(2S,4S,5S)-6-ethyl-3,4,5-trimethyloxan-2-yl]oxy-4-methyloxan-2-yl]oxy-6-ethyl-4-phenylmethoxyoxan-2-yl]oxy-6-ethyl-4-methyloxan-2-yl]oxy-6-ethyl-2,4-dimethyloxan-3-yl]acetamide

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: N-[(2S,4R,5S)-5-[(2S,5S)-3-acetamido-5-[(2S,4S,5R)-3-acetamido-5-[(2S,5S)-3-acetamido-6-ethyl-5-[(2S,4S,5S)-6-ethyl-3,4,5-trimethyloxan-2-yl]oxy-4-methyloxan-2-yl]oxy-6-ethyl-4-phenylmethoxyoxan-2-yl]oxy-6-ethyl-4-methyloxan-2-yl]oxy-6-ethyl-2,4-dimethyloxan-3-yl]acetamide
• 化学式: C₅₇H₉₄N₄O₁₄
• 分子量: 1059.4
• InChiKey: MLUOAZMYIBNUTP-YOFFEPBXSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  7.6
• 重原子数：
  75
• 可旋转键数：
  20
• 环数：
  6.0
• sp3杂化的碳原子比例：
  0.82
• 拓扑面积：
  209
• 氢给体数：
  4
• 氢受体数：
  14

文献信息

• MODULATING ANGIOGENESIS WITH NOD FACTORS SUCH AS GLUCOSAMINE OLIGOSACCHARIDES
  申请人：Parish Christopher Richard

  公开号：US20090209485A1

  公开（公告）日：2009-08-20

  This invention relates to the use of Nod factors and derivatives thereof for the modulation of blood vessel growth and development as well as compositions for modulating angiogenesis.